Fluid resuscitation for septic shock has been controversial, as some studies have found it beneficial while others question if it is. The ARISE and PROMISE trials tested early goal-directed therapy (EGDT) protocols against usual care in sepsis patients. The trials found no difference in outcomes between the EGDT and usual care groups. While EGDT involved more fluid administration, the absolute difference was small at less than 1,000ml. Overall, outcomes seem to be improving for sepsis patients with fluids, antibiotics, and source control, suggesting that the key is paying attention to patients rather than complex protocols.
5. give exactly the amount of 鍖uid that they need
and not a drop more
6. It is time to go back to basics and
challenge our entrenched
assumption that 鍖uid resuscitation
is bene鍖cial for people in septic
shock, rather than continue to
argue over which 鍖uid works
best.
10. the details
multi centre
RCT
blinded assessors but not patients or
docs
early in the sepsis course
had to get a decent bolus of 鍖u庄糸壊 before
they could get in
powered with an assumption of 35-40%
mortality
12. the results
31 centers screening 12000 pts and got
1300
no difference in primary outcome
difference in 鍖u庄糸壊 signi鍖cant but in
reality <1000ml
other differences are protocol related